post-ERCP pancreatitis
Conditions
Interventions
Control group:conventional treatment
Experimental group:conventional treatment+mirabilite for external application
Sponsors
Shuguang Hospital, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
0.5 Years to 18 Years
Inclusion criteria
Inclusion criteria: (1) Children with ERCP; (2) Aged less than 18 years; (3) male or female; (4) Voluntary participation in this experimental study and signing of informed consent form.
Exclusion criteria
Exclusion criteria: (1) The patient has organic gastroenteropathy such as upper digestive tract stenosis and obstruction; (2) Non-calculus incarcerated acute or chronic pancreatitis; (3) Severe primary diseases such as cardiovascular and cerebrovascular diseases, liver and kidney hematopoiesis, etc.; (4) Dermatological diseases such as skin ulceration or hemangioma of fresh stoma in abdomen; (5) Allergies to contrast agents such as mirabilite.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of pancreatitis; | — |
Secondary
| Measure | Time frame |
|---|---|
| visual analogue scale;Incidence of postoperative hyperamylasemia;Inflammatory response index;serum amylase;Serum lipase; | — |
Countries
China
Contacts
Public ContactDeng Zhaohui
Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine
Outcome results
None listed